Accueil>>Analytical Standards>> Reference Materials>>APP-PICA

APP-PICA

Catalog No.GC40916

PX 1 is a synthetic cannabinoid (CB) that is structurally analogous to AM2201, a potent CB receptor agonist.

Products are for research use only. Not for human use. We do not sell to patients.

APP-PICA Chemical Structure

Taille Prix Stock Qté
1mg
111,00 $US
En stock
5mg
258,00 $US
En stock
50mg
1 616,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PX 1 is a synthetic cannabinoid (CB) that is structurally analogous to AM2201 , a potent CB receptor agonist . [1]  APP-PICA is an analog of PX 1 that lacks the alkyl-terminal fluorine atom. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.

Reference:
[1]. Makriyannis, A., and Deng, H. Cannabimimetic indole derivatives. PCT/US00/28832, (2001).

Avis

Review for APP-PICA

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for APP-PICA

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.